Register Now • San Diego Awards Gala →
Serial Entrepreneur and Investor
Partner, Third Rock Ventures
Managing director, the Foundry Group
Vice president, chief strategy and operating officer of the Texas Medical Center
Founder, Gilt Groupe
Founder, Young Inventors
Executive Partner, Sofinnova Ventures
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
May 21, 2019 · Boston
May 29, 2019 · San Diego
June 13, 2019 · San Francisco
Matthew Scholz is the CEO of Immusoft, a (currently) Seattle based biotech startup that is commercializing technology to program the human immune system.
If Seattle is to occupy a future place of dominance in the biotech world, it must foster more of an “incubator” culture. There is a “valley of death” between the well-funded... Read more »
Sponsored · Whitepaper
Implementing a reliable and auditable monitoring program for life science samples, assets & equipment
Implementing electronic solutions for risk mitigation
Keep easily accessible, historical records to aid in root cause analysis for deviations
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2019, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.